Nederlands tijdschrift voor geneeskunde
-
Ned Tijdschr Geneeskd · May 1998
Review['Public health status and perspectives' 1997. I. Introduction].
The 'Public health status and forecasts' 1997 presents a comprehensive and integrated overview of health, disease and health care in the Netherlands, to which more than 250 experts contributed. On the basis of the findings, policy recommendations are formulated regarding target groups, planning, prevention, health care, monitoring and research.
-
Ned Tijdschr Geneeskd · May 1998
[A standard method for reporting ramdomized medical scientific research; the 'Consolidation of the standards of reporting trials' (CONSORT)].
The 'Consolidation of the standards of reporting trials' (CONSORT) statement was published in 1996. From that time on all manuscripts reporting randomized controlled trials (RCTs) submitted to JAMA, The Lancet or the British Medical Journal, must include a flow diagram and all the information in the CONSORT checklist. The Nederlands Tijdschrift voor Geneeskunde (Dutch Journal of Medicine) will follow suit. ⋯ The completed checklist will be sent to the editors and the reviewers but will not be published. This method of publication is also applicable to longitudinal or cross-sectional studies. By making the process of publishing trials controllable it is hoped that the quality of these manuscripts will improve and with it their use and the quality of scientific research.
-
Ned Tijdschr Geneeskd · Apr 1998
Practice Guideline Guideline[Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation].
The Netherlands Antibiotic Policy Foundation issued guidelines for empirical antimicrobial therapy of adult pneumonia patients in hospitals. A distinction is made between pneumonia contracted at home or in hospital because of the differences in micro-organisms and resistance patterns. These two categories are subdivided further with an empirical antibiotic treatment being chosen on the basis of the causative agents to be expected. ⋯ With regard to nosocomial pneumonia, treatment varies according to whether a pneumonia has or has not been contracted in the intensive care unit. Combating development of resistance is alloted an important place. Emphasis is laid on 'streamlining' the therapy, i.e. its adjustment (including choosing an antibiotic with the narrowest possible spectrum) once the causative agent is known.
-
Ned Tijdschr Geneeskd · Apr 1998
[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)].
The worldwide problem of antibiotic resistance of bacteria is a point of concern in the Netherlands as well. Responsible use of existing antibiotics was the incentive to establish a foundation, with the acronym SWAB, the primary goal of which is to optimize the use of antibiotics in the Netherlands in order to diminish the development of antibiotic resistance. One of the SWAB projects is the development of national guidelines for the use of antibiotics in hospitals. ⋯ The revised version of the guidelines is submitted for publication in this journal. The SWAB hopes that these guidelines will make the prevention of antibiotic resistance a major factor in the choice of the antibiotic. Streamlining antibiotic therapy is an important tool in this respect.